Rutgers was selected as one of five new hubs under the National Institutes of Health’s Research Evaluation and Commercialization Hubs (REACH) program to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics, and tools to improve patient care, enhance health, and train the next generation of innovators. To learn more Rutgers’ REACH hub.
Home / News / Rutgers Receives $4M as New Hub Under NIH REACH Program to Accelerate Development of Biomedical Technologies
Recent Posts
- Clinical Trials Office Webinar: Clinical Trial Agreements: The Hows, Whats, and Whys.
- Top-Ranked University’s Research Facilities Set to Nest at New Jersey Life Sciences Campus.
- New NJACTS Publication
- Rutgers Researcher Receives a $2 Million Five-Year NIH Grant to Advance New Generation of Cancer Treatments.
- Rutgers Receives $4.6 Million Federal Grant to Support Mental Health in Newark Schools.
Categories
- Community (2,116)
- Covid (980)
- CTO Events (6)
- News (2,687)
- Pilots (20)